Cera Sanitaryware is witnessing a resurgence in growth momentum, supported by strong demand recovery, improving margins, and robust capacity positioning. After a period of subdued expansion, the company is poised for double-digit growth in FY27, aided by pricing actions and easing cost pressures. Strategic investments in capacity, brand positioning, and premiumization are expected to drive long-term value. With a strong balance sheet, consistent cash flows, and favorable industry dynamics, the stock appears attractively valued after a recent correction. Motilal Oswal’s upgrade reflects confidence in earnings recovery and margin expansion over the next two years.

Stock Upgrade Driven by Valuation Comfort and Earnings Visibility

Cera Sanitaryware has been upgraded to BUY with a revised target price of Rs 5,990, underpinned by improving earnings visibility and attractive valuations. Following a ~15% correction from its February 2026 peak, the stock now trades at approximately 19.5x FY28E earnings, significantly below its historical 10-year average of ~33x.

This valuation gap, coupled with expected earnings growth, presents a compelling entry point for investors seeking exposure to India’s building products sector.

Demand Momentum Rebounds Strongly

The company has regained growth traction, reporting double-digit revenue momentum in recent quarters. After experiencing muted growth of below 5% during the second half of FY24, demand conditions have improved meaningfully.

Management expects:

Double-digit revenue growth in 4QFY26
Sustained double-digit expansion through FY27

This recovery is being driven by strong retail demand, improving real estate activity, and rising premiumization trends across Tier 2 and Tier 3 markets.

Margin Pressures Easing, Recovery in Sight

Margins had contracted due to multiple transient factors, including:

Elevated trade discounts from higher project sales mix
Rising brass prices
Increased promotional and branding expenses
Costs related to new product launches

However, these pressures are expected to ease.

Management guidance indicates:

EBITDA margins of 13–14% in 4QFY26
Expansion to 15%+ levels from 2HFY27 onwards

This margin recovery will be a key driver of earnings growth over the medium term.

Strategic Price Hikes to Protect Profitability

Cera has proactively implemented price increases to counter input cost inflation:

4% hike in sanitaryware
11% hike in faucetware

These pricing actions are expected to partially offset raw material inflation while maintaining margin discipline without significantly impacting demand.

Operational Stability Provides Competitive Advantage

One of the standout positives for Cera is its uninterrupted production capability.

While several Morbi-based competitors faced disruptions due to gas supply cuts, Cera maintained stable operations with:

100% gas supply from GAIL
80% supply from Sabarmati

This ensured continuity in production and helped the company capitalize on demand during a period of industry disruption.

Capacity Expansion and Growth Optionality

The company is well-positioned to scale capacity in line with demand growth:

Faucetware capacity can be increased from 0.4 million to 0.6 million units within 4–6 months
Sanitaryware plants are currently operating at ~80% utilization
A new greenfield facility near Kadi, Gujarat, is under consideration

These initiatives provide significant headroom for future growth without immediate heavy capital expenditure.

Diversified Product Portfolio Driving Revenue Mix

Cera has evolved from a sanitaryware-focused company into a diversified bathware player.

Key highlights:

Faucetware contributes ~39% of revenue
Sanitaryware accounts for ~49%
Tiles and wellness segments add incremental diversification

Notably, faucetware has emerged as a high-margin segment, delivering strong growth and profitability.

Strong Financials and Cash Flow Visibility

Cera’s financial profile remains robust, supported by disciplined capital allocation and strong cash generation.

Key projections:

Revenue CAGR of ~11% over FY26–FY28
EBITDA CAGR of ~23%
PAT CAGR of ~20%

Additionally:

Expected cash surplus of ~Rs 10 billion by FY28
Strong free cash flow generation driven by efficient working capital management

This financial strength provides resilience during cyclical downturns.

Brand Strategy and Premiumization Focus

The company is sharpening its brand positioning across segments:

Senator and CERA Luxe target premium customers
Polipluz focuses on volume growth through distribution expansion

The ongoing premiumization trend, especially in Tier 2 and Tier 3 markets, is expected to significantly benefit the company’s product mix and margins.

Key Financial Snapshot

Investment View: A Well-Timed Opportunity

Cera Sanitaryware presents a compelling investment case at current levels, driven by:

Recovery in demand momentum
Margin expansion visibility
Strong balance sheet and cash flows
Strategic capacity expansion
Attractive valuation post-correction

With a target price of Rs 5,990, the stock offers meaningful upside potential, making it an attractive BUY for medium-term investors seeking exposure to India’s consumption and housing growth story.